HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Desport, J. C Articles by Couratier, P. P Search for Related Content PubMed PubMed Citation Articles by Desport, J. C Articles by Couratier, P. P Agricola Articles by Desport, J. C Articles by Couratier, P. P

Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis^1,2,3

¹ From the Nutrition Unit & Hepato-Gastroenterology Service (JCD), the Clinical Research and Biostatistic Unit (PMP), the Rheumatology Service (CB), and the Neurology Service (PPC), Dupuytren University Hospital, Limoges, France, and the Human Nutrition Laboratory (CB-D and BB) and Neurology Service (PC), University Hospital, Clermont-Ferrand, France.

Background: Amyotrophic lateral sclerosis (ALS) is a neurologic disease with an unfavorable prognosis that may be accompanied by malnutrition or overweight. Nutritional status is difficult to evaluate in these patients because of their physical limitations and the asymmetry of their disease involvement. Bioelectrical impedance analysis (BIA), which enables bedside analysis of body compartments, has not been adequately validated for use in patients with ALS.

Objective: We compared reference measures of fat-free mass (FFM_a), obtained by dual-energy X-ray absorptiometry, with FFM obtained by BIA and by the skinfold-thickness technique.

Design: We measured FFM_a in 32 ALS patients. Anthropometric measures included weight, height, skinfold thickness, and arm and wrist circumferences. The fat mass obtained from the skinfold-thickness measures enabled us to calculate FFM. BIA was performed by measuring the bioimpedances at 5, 50, and 100 kHz of each side of the body and from one side to the other. FFM was calculated by using the instrument’s internal software and by using 3 standard equations. The concordance between the methods was evaluated by the Bland-Altman test.

Results: Two of the 16 measured FFM values were not significantly different from FFM_a. However, the risk of dispersion was too high to be acceptable in practice. An equation was then developed by using multivariate analysis, with impedance at 50 kHz. This equation was validated in a second population of 15 ALS patients and with the use of 2 successive measurements performed on 18 patients.

Conclusion: BIA is a simple technique that is valid for use in ALS patients, both for a single exam measure and for longitudinal monitoring, with the use of an adapted equation and a frequency of 50 kHz.

This article has been cited by other articles:

				D. Gupta, C. A Lammersfeld, J. L Burrows, S. L Dahlk, P. G Vashi, J. F Grutsch, S. Hoffman, and C. G Lis Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1634 - 1638. [Abstract] [Full Text] [PDF]